| Literature DB >> 26804231 |
Yin-Bo Fan1, Kun Li1, Min Huang1, Yu Cao1, Ying Li2, Shu-Yu Jin1, Wen-Bing Liu1, Jia-Chen Wen1, Dan Liu3, Lin-Xiang Zhao4.
Abstract
A novel series of substituted pyrido[3,2-d]-1,2,3-triazines were designed and synthesized as Pim-1 inhibitors through scaffold hopping. Most of the derivatives showed potent in vitro Pim-1 inhibitory activities and anti-proliferative effects toward prostate cancer cells. Among them, 6b, 6h and 6m showed the best Pim-1 inhibitory activity with IC50 values of 0.69, 0.60 and 0.80 μM, respectively. Furthermore, compounds 6b, 6i, 6j and 6m showed strong inhibitory activity to human prostate cancer LNcap and PC-3 cell lines with IC50 values at low micromolar level. Structure-activity relationship analysis revealed that appropriate substitutions at C-6 positions contributed to the kinase inhibition and antiproliferative effects. Moreover, western blot assay suggested that 6j could decrease the levels of p-BAD and p-4E-BP1 in a dose-dependent manner in PC-3 cells. Docking studies showed that 3-N of the scaffold formed a hydrogen bond with Lys67, aromatic 4-aniline formed a key π-π stack with Phe49. Taken together, this study might provide the first sight for developing the pyrido[3,2-d]-1,2,3-triazine scaffold as novel Pim-1 inhibitors.Entities:
Keywords: Anti-proliferative activity; Pim-1 kinase inhibitors; Prostate cancer cells; Pyrido[3,2-d]-1,2,3-triazines
Mesh:
Substances:
Year: 2016 PMID: 26804231 DOI: 10.1016/j.bmcl.2016.01.032
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823